Mirae Asset Healthcare Fund · Regular · Growth
NAV
₹45.5420
as of 31 Jul 2026
Expense Ratio
1.93%
AUM
₹2,978 Cr
Lumpsum returns (CAGR)
- 1Y
- +14.50%
- 3Y
- +21.98%
- 5Y
- +14.40%
- Since Inception
- +20.64%
SIP returns (XIRR)
- 1Y
- +30.35%
- 3Y
- +19.87%
- 5Y
- +19.47%
- Since Inception
- +21.04%
What history actually did — last 8 years (Aug 2018 – Jul 2026)
A ₹5,000 monthly SIP for the last 8 years (Aug 2018 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹11,11,123 today — ₹4,75,000 invested, 21.0% XIRR.
₹4,75,000
Invested
₹11,11,123
Value today
21.0%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 8 years (Aug 2018 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 8 years ago would be ₹4,46,665 today (20.6% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Aug 2018 would still hold ₹33,55,530.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹11,11,123 in this fund vs ₹8,49,456 in the benchmark — outperformance of ₹2,61,667.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 8 years (Aug 2018 – Jul 2026) (22 Mar 2020) would be ₹4,70,718 today (4.71×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.55
Sharpe Ratio
+0.13
Alpha
0.20
Beta
0.51
Sortino
14.82%
Std Dev
-10.78%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Jun 2026Each sector links to the mutual funds most exposed to it.
Thinking about Mirae Asset Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Mirae Asset Healthcare Fund Regular IDCW
- 1Sun Pharmaceutical Industries Ltd.10.95%
- 2Divi'S Laboratories Ltd.7.53%
- 3Jb Chemicals & Pharmaceuticals Ltd.6.49%
- 4Apollo Hospitals Enterprise Ltd.6.09%
- 5Glenmark Pharmaceuticals Ltd.6.09%
- 6Laurus Labs Ltd.4.61%
- 7Dr. Reddy'S Laboratories Ltd.4.33%
- 8Aurobindo Pharma Ltd.4.33%
- 9Lupin Ltd.4.13%
- 10Krishna Institute Of Medical Sciences Ltd.3.85%
Investment Objective
Mirae Asset Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Mirae Asset Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Mirae Asset Mutual Fund. The fund has been operational for over 8 years. It manages assets worth ₹2,978 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 1.93%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations